John D. Manders - 11 Aug 2021 Form 4 Insider Report for SURMODICS INC (SRDX)

Role
Corporate Controller
Signature
/s/ John D. Manders
Issuer symbol
SRDX
Transactions as of
11 Aug 2021
Net transactions value
-$79,282
Form type
4
Filing time
13 Aug 2021, 10:13:08 UTC
Previous filing
20 Jul 2021
Next filing
29 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SRDX Common Stock Options Exercise $59,854 +2,608 +84% $22.95 5,716 11 Aug 2021 Direct
transaction SRDX Common Stock Sale $136,261 -2,555 -45% $53.33 3,161 11 Aug 2021 Direct F1
transaction SRDX Common Stock Sale $2,875 -53 -1.7% $54.24 3,108 11 Aug 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SRDX Employee Stock Option (right to buy) Options Exercise $0 -2,608 -100% $0.000000* 0 11 Aug 2021 Common Stock 2,608 $22.95 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the weighted average price of 2,555 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on August 11, 2021 with sale prices ranging from $53.1458 to $53.72 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F2 Fully vested.